{"Symbol": "AGTC", "AssetType": "Common Stock", "Name": "Applied Genetic Technologies Corporation", "Description": "Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. The company's advanced product candidates consist of three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials. The company also has initiated one preclinical program in otology and three preclinical programs in targeting central nervous system disorders, including one in adrenoleukodystrophy. Applied Genetic Technologies Corporation has collaboration agreements with Synpromics Limited and University of Florida; Bionic Sight, LLC; and Otonomy, Inc. The company was founded in 1999 and is headquartered in Alachua, Florida.", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "Healthcare", "Industry": "Biotechnology", "Address": "14193 NW 119th Terrace, Alachua, FL, United States, 32615", "FullTimeEmployees": "85", "FiscalYearEnd": "June", "LatestQuarter": "2020-03-31", "MarketCapitalization": "133208152", "EBITDA": "-3077000", "PERatio": "None", "PEGRatio": "0", "BookValue": "3.292", "DividendPerShare": "None", "DividendYield": "0", "EPS": "-0.11", "RevenuePerShareTTM": "0.149", "ProfitMargin": "0", "OperatingMarginTTM": "-15.3207", "ReturnOnAssetsTTM": "-0.2658", "ReturnOnEquityTTM": "-0.4841", "RevenueTTM": "2859000", "GrossProfitTTM": "27864000", "DilutedEPSTTM": "-2.181", "QuarterlyEarningsGrowthYOY": "0", "QuarterlyRevenueGrowthYOY": "-0.587", "AnalystTargetPrice": "15.44", "TrailingPE": "0", "ForwardPE": "0", "PriceToSalesRatioTTM": "33.8038", "PriceToBookRatio": "1.528", "EVToRevenue": "17.6863", "EVToEBITDA": "0", "Beta": "2.5951", "52WeekHigh": "9.5", "52WeekLow": "2.29", "50DayMovingAverage": "5.5793", "200DayMovingAverage": "4.7807", "SharesOutstanding": "25765600", "SharesFloat": "22689464", "SharesShort": "2949163", "SharesShortPriorMonth": "1847970", "ShortRatio": "10.64", "ShortPercentOutstanding": "0.1", "ShortPercentFloat": "0.0979", "PercentInsiders": "0.932", "PercentInstitutions": "48.185", "ForwardAnnualDividendRate": "0", "ForwardAnnualDividendYield": "0", "PayoutRatio": "0", "DividendDate": "None", "ExDividendDate": "None", "LastSplitFactor": "None", "LastSplitDate": "None"}